# US 2016/0355569 A1 · Surface, anchored fc-bait antibody display system

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0355569 A1
- Document ID: US20160355569A1
- Status: Published application
- Kind: A1
- Application number: 15/164,773
- Filed: 2016-05-25
- Published: 2016-12-08
- Earliest claimed: 2013-08-06
- Assignees: Merck Sharp & Dohme Corp.
- Inventors: Dougxing Zha; Hussam Hisham Shaheen
- Web page: https://patentgrep.com/patent/US20160355569A1

## CPC

- C07K 16/00: Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K 16/005: {constructed by phage libraries}
- C07K 16/32: against translation products of oncogenes
- C07K 16/40: against enzymes
- G01N 33/6845: {Methods of identifying protein-protein interactions in protein mixtures}
- G01N 33/6854: {Immunoglobulins}
- C07K 2317/14: Specific host cells or culture conditions, e.g. components, pH or temperature
- C07K 2317/35: Valency
- C07K 2317/52: Constant or Fc region; Isotype
- C07K 2319/00: Fusion polypeptide
- C07K 2319/03: containing a transmembrane segment
- C07K 2319/30: Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
- C40B 30/04: by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
- C40B 50/06: Biochemical methods, e.g. using enzymes or whole viable microorganisms
- G01N 2440/38: addition of carbohydrates, e.g. glycosylation, glycation
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C40B: COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES (in silico combinatorial libraries of nucleic acids, proteins or peptides G16B35/00; in silico combinatorial chemistry G16C20/60)

## Abstract

The present invention provides, in part, an antibody display system that simultaneously uses a secretion and a display mode. A bait complexed with a monovalent antibody fragment can be expressed on the surface of the host cell wherein the fragment may be assayed for antigen binding while full antibody is simultaneously secreted from the host cell. Methods of using the system for identifying antibodies that bind specifically to an antigen of interest are also provided. Polypeptides, polynucleotides and host cells useful for making the antibody display system are also provided along with methods of use thereof.

## Claims

### Claim 1

An antibody display system comprising:
(a) an isolated host cell;
(b) a bait comprising a heavy Fc immunoglobulin domain fused to a surface anchor polypeptide;
(c) one or more polynucleotides encoding an immunoglobulin light chain variable region; and
(d) one or more polynucleotides encoding an immunoglobulin heavy chain variable region.

### Claim 2 (depends on 1)

The antibody display system of claim 1 further comprising
(i) a non-tethered full antibody comprising said immunoglobulin light and heavy chains; and/or
(ii) a monovalent antibody fragment which is complexed with the Fc moiety of the bait.

### Claim 3 (depends on 1, 2)

The antibody display system of any one of claims 1-2 wherein the host cell is a Pichia cell.

### Claim 4 (depends on 1, 2, 3)

The antibody display system of any one of claims 1-3
wherein said one or more polynucleotides encoding an immunoglobulin light chain variable region is from a genetically diverse population of immunoglobulin light chain variable regions; and/or,
wherein said one or more polynucleotides encoding an immunoglobulin heavy chain variable region is from a genetically diverse population of immunoglobulin heavy chain variable regions.

### Claim 5 (depends on 1, 2, 3, 4)

The antibody display system of any one of claims 1-4 wherein the host cell comprises a polynucleotide encoding the bait which is operably associated with a regulatable promoter.

### Claim 6

An isolated bait polypeptide comprising an Fc immunoglobulin domain or functional fragment thereof fused, optionally by a peptide linker, to a surface anchor polypeptide or functional fragment thereof; which bait polypeptide is optionally amino-terminally fused to a signal peptide.

### Claim 7 (depends on 6)

The polypeptide of claim 6 wherein the surface anchor polypeptide is SED-1 or a functional fragment thereof.

### Claim 8 (depends on 6, 7)

The polypeptide of any one of claims 6-7 wherein the Fc immunoglobulin domain is an IgG1, IgG2, IgG3 or IgG4 immunoglobulin.

### Claim 9 (depends on 6, 7, 8)

An isolated polynucleotide encoding the polypeptide of any one of claims 6-8.

### Claim 10 (depends on 9)

A vector comprising the polynucleotide of claim 9.

### Claim 11 (depends on 6, 7, 8)

An isolated host cell comprising the polypeptide of any one of claims 6-8 or a polynucleotide encoding said polypeptide.

### Claim 12 (depends on 11)

The host cell of claim 11 further comprising one or more polynucleotides encoding an immunoglobulin light chain variable region; and/or one or more polynucleotides encoding an immunoglobulin heavy chain variable region.

### Claim 13 (depends on 11, 12)

The host cell of any one of claims 11-12 which is a Pichia cell.

### Claim 14 (depends on 11, 12, 13)

The host cell of any one of claims 11-13 wherein the polypeptide is located on the surface of the cell membrane.

### Claim 15 (depends on 11, 12, 13, 14)

A composition comprising the host cell of any one of claims 11-14, further comprising a non-tethered full antibody comprising said immunoglobulin light and heavy chains; and/or an Fc/antigen-binding fragment of an antibody which is complexed with the Fc moiety of the bait; optionally, wherein said full antibody or Fc/antigen-binding fragment is complexed with an antigen of interest.

### Claim 16

A method for determining if an antibody or antigen-binding fragment thereof specifically binds to an antigen comprising contacting an antibody display system with said antigen; wherein the antibody display system comprises:
(a) an isolated eukaryotic host cell comprising a polynucleotide encoding an immunoglobulin light chain; and a polynucleotide encoding an immunoglobulin heavy chain; and
(b) a bait comprising an Fc immunoglobulin domain or functional fragment thereof fused to a surface anchor polypeptide or functional fragment thereof on the surface of said eukaryotic host cell;
wherein the Fc of said bait complexes with an Fc/antigen-binding fragment comprising said immunoglobulin heavy and immunoglobulin light chains on the surface of the host cell;
and determining if said Fc/antigen-binding fragment specifically binds to said antigen;
wherein the antibody is determined to specifically bind said antigen if the monovalent antibody fragment specifically binds to said antigen.

### Claim 17

A method for identifying:
(i) an antibody or antigen-binding fragment thereof that binds specifically to an antigen; or
(ii) a polynucleotide encoding an immunoglobulin heavy chain of said antibody or fragment and/or a polynucleotide encoding an immunoglobulin light chain of said antibody or fragment;
comprising contacting an antibody display system with said antigen wherein the antibody display system comprises:
(a) an isolated eukaryotic host cell comprising a polynucleotide encoding an immunoglobulin light chain; and a polynucleotide encoding an immunoglobulin heavy chain; and
(b) a bait comprising an Fc immunoglobulin domain or functional fragment thereof fused to a surface anchor polypeptide or functional fragment thereof on the surface of said eukaryotic host cell;
wherein the Fc of said bait complexes with an Fc/antigen-binding fragment comprising said immunoglobulin heavy and immunoglobulin light chains on the surface of the host cell;
and determining if said Fc/antigen-binding fragment specifically binds to said antigen;
wherein the antibody or fragment or polynucleotide is identified if said specific binding to said antigen is observed.

### Claim 18 (depends on 16, 17)

The method of any one of claims 16-17 further comprising isolating the identified polynucleotides.

### Claim 19 (depends on 16, 17, 18)

The method of any one of claims 16-18 further comprising inhibiting expression of said bait, then determining the affinity of said identified antibody or antigen-binding fragment thereof for said antigen.

### Claim 20 (depends on 16, 17, 18, 19)

The method of any one of claims 16-19 further comprising recombinantly expressing the immunoglobulin chains encoded by the polynucleotides and, optionally, isolating an antibody or antigen-binding fragment thereof comprising said immunoglobulins and, optionally, producing a pharmaceutical formulation comprising combining said antibody or antigen-binding fragment thereof and a pharmaceutically acceptable carrier.

### Claim 21

A method for making an antibody display system comprising:
(a) an isolated eukaryotic host cell;
(b) a bait comprising a human Fc immunoglobulin domain fused to a surface anchor polypeptide;
(c) one or more polynucleotides encoding an immunoglobulin light chain variable region;
(d) one or more polynucleotides encoding an immunoglobulin heavy chain variable region;
comprising introducing, into said eukaryotic host cell, a polynucleotide encoding said bait, said one or more polynucleotides encoding an immunoglobulin light chain variable region; and said one or more polynucleotides encoding an immunoglobulin heavy chain variable region.

### Claim 22

A method for making an antibody or antigen-binding fragment thereof comprising introducing, into an isolated eukaryotic host cell comprising a bait that includes a human Fc immunoglobulin domain or functional fragment thereof fused to a surface anchor polypeptide or functional fragment thereof, one or more polynucleotides encoding an immunoglobulin light chain variable region; and/or one or more polynucleotides encoding an immunoglobulin heavy chain variable region; and culturing the host cell under condition whereby the polynucleotides encoding the immunoglobulin chains are expressed and an antibody or antigen-binding fragment thereof is formed from said chains; wherein said bait is operably associated with a regulatable promoter and bait expression is inhibited when said immunoglobulin chains are expressed.

### Claim 22

A method for making an antibody or antigen binding fragment thereof comprising culturing an isolated eukaryotic host cell in a growth medium under conditions allowing expression of an immunoglobulin light chain and an immunoglobulin heavy chain of said antibody or fragment; wherein the eukaryotic host cell comprises:
(i) a polynucleotide encoding said immunoglobulin light chain; and a polynucleotide encoding said immunoglobulin heavy chain of said antibody or fragment; and
(ii) a bait comprising an Fc immunoglobulin domain or functional fragment thereof fused to a surface anchor polypeptide or functional fragment thereof on the surface of said eukaryotic host cell;
wherein the Fc of said bait complexes with an Fc/antigen-binding fragment comprising said immunoglobulin heavy and immunoglobulin light chains on the surface of the host cell; and wherein the expression of the bait is optionally inhibited; wherein said antibody or fragment is optionally secreted from said eukaryotic host cell; optionally comprising isolating said antibody or fragment from said eukaryotic host cell and medium.

### Claim 23

A method for determining the effect of a sugar on an antibody or antigen-binding fragment thereof which specifically binds to an antigen comprising contacting an antibody display system with said antigen; wherein the antibody display system comprises:
(a) an isolated eukaryotic controlled glycosylation host cell comprising a polynucleotide encoding an immunoglobulin light chain; and a polynucleotide encoding an immunoglobulin heavy chain; and
(b) a bait comprising an Fc immunoglobulin domain or functional fragment thereof fused to a surface anchor polypeptide or functional fragment thereof on the surface of said eukaryotic host cell;
wherein the Fc of said bait complexes with an Fc/antigen-binding fragment comprising said immunoglobulin heavy and immunoglobulin light chains on the surface of the host cell; wherein said heavy or light chain comprises said sugar;
determining if said Fc/antigen-binding fragment specifically binds to said antigen;
determining the binding affinity of the antibody or antigen-binding fragment thereof comprising said sugar for the antigen; and
comparing the affinity of the antibody or antigen-binding fragment thereof with affinity of an otherwise identical antibody or antigen-binding fragment thereof which lacks said sugar;
wherein the sugar is determined to increase affinity for the antigen if the affinity of the antibody or antigen-binding fragment thereof comprising said sugar is higher than the affinity of the antibody or antigen-binding fragment thereof which lacks the sugar, and/or wherein the sugar is determined to decrease affinity for the antigen if the affinity of antibody or antigen-binding fragment thereof comprising said sugar is lower than the affinity of the antibody or antigen-binding fragment thereof which lacks the sugar.
